Text reading "The only 5 in one meningitis vaccine" Text reading "The only 5 in one meningitis vaccine"

About PENBRAYA™

(Meningococcal Groups A, B, C, W, and Y Vaccine)

Style
Inner banner, hero-subheading

Style
colorheroline, section-break

PENBRAYA protection

PENBRAYA is the only FDA-approved vaccine that helps protect your teen from all 5 leading types of meningococcal meningitis—A, B, C, W, and Y—with fewer shots. PENBRAYA combines 2 meningitis vaccines that have helped protect teens for nearly 10 years.*

One vaccine protects against types A, C, W, and Y and the other against type B.

Only PENBRAYA helps protect against all 5 leading types of meningococcal meningitis—A, B, C, W, and Y
Style
Injection column sec, section-break, supercript star

When should my teen get PENBRAYA?

A meningitis vaccination schedule showing that teens typically receive their first meningitis shot at age 11 or 12 for types A,C,W, and Y, and at age 16 they can get PENBRAYA (Meningococcal groups A,B,C,W, and Y). A meningitis vaccination schedule showing that teens typically receive their first meningitis shot at age 11 or 12 for types A,C,W, and Y, and at age 16 they can get PENBRAYA (Meningococcal groups A,B,C,W, and Y).

Help protect your teen from all 5 leading types of meningococcal meningitis with 1 less required shot. By vaccinating your healthy teen with PENBRAYA at age 16, they can:

Actor portrayal of an older teen driving a car and text reading "Talk to your teen's doctor about whether 5-in-1 PENBRAYA (Meningococcal groups A,B,C,W, and Y) is right for them. Actor portrayal of an older teen driving a car and text reading "Talk to your teen's doctor about whether 5-in-1 PENBRAYA (Meningococcal groups A,B,C,W, and Y) is right for them.
Style
Inner-banner, round-banner, age-image-container, section-break

Safety profile

The safety of PENBRAYA was researched in 3 clinical studies. 2306 participants ranging in age from 10 to 25 years received at least 1 dose of PENBRAYA.

The studies compared how participants’ immune systems responded following vaccination with:

Logo for PENBRAYA™ (Meningococcal Groups A,B,C,W, and Y Vaccine)

or

An existing vaccine for types A, C, W, and Y

An existing vaccine for type B

Participants experienced similar side effects whether they received PENBRAYA or the 2 existing vaccines.

The most common side effects were pain at the injection site, fatigue, headache, muscle pain, injection site redness, injection site swelling, joint pain, and chills.

Style
Light Pink Bg, safety profile sec

Style
Colorheroline, Light Pink Bg, section break

Is your teen protected against all 5 leading types of meningococcal meningitis?

Use our discussion guide to start a conversation with your teen’s doctor.

Get discussion guide

Previous: Isn’t my teen vaccinated?

Next: FAQs

Style
next-previous-buttons